Dr N. K. Arora said Biological E’s made-in-India vaccine is expected to have 90 per cent effectiveness against COVID-19 and would likely be a game changer in the fight against the pandemic.
Arora, Head of India’s COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI), said this on Thursday.
Arora in an interview with a local television news channel NDTV said the vaccine is entering Phase 3 trials and could be available by October.
According to Arora, Biological E’s vaccine to be called Corbevax is similar to the Novavax vaccine.
Biological E will be out likely in October with an efficacy matching Novavax’s.
India started the vaccination against COVID-19 on Jan. 16, by administrating two made in India vaccines namely Covishield and Covaxin.
Recently, Russian COVID-19 vaccine Sputnik V too was rolled out in the country.
Xinhua
